Adverse events with pemigatinib in the real world: a pharmacovigilance study based on the FDA Adverse Event Reporting System.

Journal: Expert opinion on drug safety

Publication date: 

Journal: Expert opinion on drug safety

Publication Year: 

Authors & Co-authors:  Zhao Long Wang